Deleting Database and Emails: a Fatal Flaw of AI Agents Leads to Risks in Human–AI Collaboration

On January 29, Chinese developer Qu Jiangfeng was using Antigravity AI, a product of Google DeepMind, to clean up project ...

Literacy Research Association announces Major Keynote for Honolulu 2026 Conference

Information concerning registration for the LRA 2026 conference, which will include a keynote address by Dr. Yolanda Sealey-Ruiz, is expected to be released shortly on the Literacy Research ...

Recursion jumps after solid Q4 beat

Recursion Pharmaceuticals (RXRX) stock surged after the company significantly beat Street forecasts with its Q4 2025 results.

Recursion outlines extended cash runway into early 2028 as platform efficiency accelerates

Guidance extended from year-end 2027 to early 2028, with operating expense reduction targets reiterated and achieved at a greater scale (now 35% year-over-year, 10% below guidance). Strategic focus ...

Recursion Pharmaceuticals Shares Rise After 4Q Revenue Increase

Recursion Pharmaceuticals shares were 11% higher, at $3.90, after the company reported fourth-quarter revenue that was higher than last year, and a loss that was narrower than last year's.